Literature DB >> 19342865

Vasculitic IgA nephropathy: prognosis and outcome.

Tanya Pankhurst1, Julia Lepenies, Peter Nightingale, Alexander J Howie, Dwomoa Adu, Lorraine Harper.   

Abstract

BACKGROUND: A vasculitic glomerulonephritis is seen in both IgA nephropathy and Henoch-Schonlein purpura. No study has examined prognostic factors in vasculitic IgA nephropathy.
METHODS: All patients with vasculitic IgA presenting to our centre between January 1996 and May 2003 were retrospectively reviewed by analysis of clinical and pathological features at presentation and during follow-up.
RESULTS: Of 363 patients with IgA nephropathy, 67 patients had vasculitic IgA nephropathy (33 Henoch-Schönlein purpura; 34 IgA). Median length of follow-up was 32.38 months (range 0-90). Median glomerular filtration rate at presentation was 45.56 ml/min (range 4-110), arterial blood pressure 104.67 mm Hg and proteinuria 1.19 g/24 h (range 0-14.8) falling during follow-up to 0.11 g (range 0-3.1). Median chronic damage at presentation in the biopsy was 10% (range 0-91). The majority (79%) were immunosuppressed with 84% patient survival and 85% renal survival at 60 months. Three factors significantly affected renal outcome: renal function; blood pressure at presentation and the amount of chronic damage in the biopsy. The effect of immunosuppression on outcome was difficult to comment on as treated and untreated groups were not comparable.
CONCLUSIONS: Presenting renal function, blood pressure and chronic damage in the biopsy are important prognostic factors in vasculitic IgA nephropathy. Immunosuppression is advocated in some patients. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19342865     DOI: 10.1159/000210570

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  5 in total

1.  Prediction of outcomes in crescentic IgA nephropathy in a multicenter cohort study.

Authors:  Jicheng Lv; Yihe Yang; Hong Zhang; Wenfang Chen; Xiaoxia Pan; Zhiling Guo; Caili Wang; Shen Li; Jianrong Zhang; Jianchun Zhang; Lijun Liu; Sufang Shi; Suxia Wang; Min Chen; Zhao Cui; Nan Chen; Xueqing Yu; Minghui Zhao; Haiyan Wang
Journal:  J Am Soc Nephrol       Date:  2013-09-12       Impact factor: 10.121

Review 2.  Treatment of IgA nephropathy and Henoch-Schönlein nephritis.

Authors:  Jürgen Floege; John Feehally
Journal:  Nat Rev Nephrol       Date:  2013-04-02       Impact factor: 28.314

3.  Non-infectious aortitis in an immunosuppressed renal transplant recipient with IgA nephropathy.

Authors:  Charlotte M Snead; Stephen C Crockett; Phillippa K Bailey
Journal:  BMJ Case Rep       Date:  2017-10-19

4.  Clinicopathological characteristics and prognosis of patients with IgA nephropathy and renal vasculitic lesions.

Authors:  Xueqing Tang; Qiong Wen; Qian Zhou; Wei Chen
Journal:  BMC Nephrol       Date:  2021-10-28       Impact factor: 2.388

5.  Chapter 10: Immunoglobulin A nephropathy.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.